AU1740197A - Vaccine against hantavirus - Google Patents

Vaccine against hantavirus

Info

Publication number
AU1740197A
AU1740197A AU17401/97A AU1740197A AU1740197A AU 1740197 A AU1740197 A AU 1740197A AU 17401/97 A AU17401/97 A AU 17401/97A AU 1740197 A AU1740197 A AU 1740197A AU 1740197 A AU1740197 A AU 1740197A
Authority
AU
Australia
Prior art keywords
vaccine against
against hantavirus
hantavirus
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU17401/97A
Inventor
ake Lundkvist
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SBL Vaccin AB
Original Assignee
SBL Vaccin AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SBL Vaccin AB filed Critical SBL Vaccin AB
Publication of AU1740197A publication Critical patent/AU1740197A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/12011—Bunyaviridae
    • C12N2760/12111—Hantavirus, e.g. Hantaan virus
    • C12N2760/12122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU17401/97A 1996-02-06 1997-02-06 Vaccine against hantavirus Abandoned AU1740197A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9600436 1996-02-06
SE9600436A SE9600436D0 (en) 1996-02-06 1996-02-06 Vaccine against hantavirus
PCT/SE1997/000180 WO1997028819A1 (en) 1996-02-06 1997-02-06 Vaccine against hantavirus

Publications (1)

Publication Number Publication Date
AU1740197A true AU1740197A (en) 1997-08-28

Family

ID=20401291

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17401/97A Abandoned AU1740197A (en) 1996-02-06 1997-02-06 Vaccine against hantavirus

Country Status (3)

Country Link
AU (1) AU1740197A (en)
SE (1) SE9600436D0 (en)
WO (1) WO1997028819A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0100011D0 (en) * 2001-01-03 2001-01-03 Eurocine Ab Karolinska Inst Sc Virus vaccine formulation
WO2018017922A2 (en) 2016-07-22 2018-01-25 Massachusetts Institute Of Technology Selective bfl-1 peptides
EP3852783A1 (en) * 2018-09-17 2021-07-28 Massachusetts Institute of Technology Peptides selective for bcl-2 family proteins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837441A (en) * 1993-08-25 1998-11-17 University Of New Mexico Hantavirus-associated respiratory distress virus antigens

Also Published As

Publication number Publication date
SE9600436D0 (en) 1996-02-06
WO1997028819A1 (en) 1997-08-14

Similar Documents

Publication Publication Date Title
AU4781297A (en) Vaccines
AU9623898A (en) Vaccines
AU3550197A (en) Syringes
AUPO203996A0 (en) Therapeutic uses
AU2839997A (en) Medical devices
EP0958373A4 (en) Vaccines
AU3948197A (en) Medical cryo-surgical device
AUPO434196A0 (en) An improved therapeutic
GB9626864D0 (en) Vaccine
EP0800840A3 (en) Peristaltic infusionpump
AU3038697A (en) Meningococcal vaccine
AU4636396A (en) Antiglucocorticoid medicament
AU3552797A (en) Vaccine preparations
AU1740197A (en) Vaccine against hantavirus
AU8155898A (en) Human preprotachykinin b
AU2574197A (en) Dhea combination therapy
AU1645599A (en) Human matrilin-3
AU6075498A (en) Vaccines
GB9625968D0 (en) Vaccine
AU2836997A (en) Sterilization
AU4156096A (en) Non-infective vaccines
AU6932396A (en) Easy-to-store coffin
GB9609252D0 (en) Vaccines
AU765013C (en) Tuberculosis vaccines
AU3978697A (en) Plasmin-depletion therapy